Hooshware

ESTABLISHING NEURAL LINK...

Back to News Radar

Funding2w ago

Superluminal Medicines Raises $60M Series B to Advance Obesity Drug

Superluminal Medicines has successfully raised $60 million in an oversubscribed Series B financing round led by BVF Partners, L.P. The company plans to use the…

Unite.AI Read original report

#AI in drug discovery#Series B#Obesity drug#Biotechnology#Funding#AI#Machine Learning#Announced#Release

Observed across 1 source

1 editorial report · 0 verified social mentions. The most authoritative report leads while later evidence completes the story.

Unite.AIPrimary source

Superluminal Medicines Raises $60M Series B to Advance Obesity Drug

Open report

BTC—

SYNCING

ETH—

SYNCING

NVDA—

SYNCING

MSFT—

SYNCING

Customize

Superluminal Medicines Raises $60M Series B to Advance Obesity Drug | Hooshware